Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06987708) titled 'Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers' on May 16.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Hackensack Meridian Health
Condition:
Monoclonal Gammopathy of Uncertain Significance
Smoldering Myeloma
Intervention:
Other: The Multimodal Lifestyle Intervention
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: June 2025
Target Sample Size: 67
To know more, visit https://clinicaltri...